A share price of Cardlytics Inc [CDLX] is currently trading at $2.03, up 20.83%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CDLX shares have gain 13.41% over the last week, with a monthly amount glided 13.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on October 11, 2024, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $4. Previously, Northland Capital downgraded its rating to Market Perform on August 16, 2024, and kept the price target unchanged to $5. On August 15, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $3.50 on the stock. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to a Hold and reduced its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to Hold for this stock on August 08, 2024.
Cardlytics Inc experienced fluctuations in its stock price throughout the past year between $1.22 and $9.48. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $2.03 at the most recent close of the market. An investor can expect a potential return of 47.78% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
Trailing Twelve Months sales for Cardlytics Inc [NASDAQ:CDLX] were 272.59M which represents -8.45% decline. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.65%, and Net Profit Margin reading is -0.65%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -1.72 and Total Capital is -0.81. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 3.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cardlytics Inc [NASDAQ:CDLX] is 1.19. In addition, the Quick Ratio stands at 1.19 and the Cash Ratio stands at 0.39. Considering the valuation of this stock, the price to sales ratio is 0.39, the price to book ratio is 1.65.
Transactions by insiders
Recent insider trading involved Gupta Amit, Chief Executive Officer, that happened on Jul 02 ’25 when 6725.0 shares were sold. Chief Financial Officer, DeSieno Alexis completed a deal on Jul 02 ’25 to sell 7324.0 shares. Meanwhile, Chief Legal & Privacy Officer Lynton Nicholas Hollmeyer sold 5271.0 shares on Jul 02 ’25.
